Table 1.

Weight ratios of the membrane‐permeable peptides in their conjugates (mice,iv injection. aa denotes the amino acid residue)

	Dosage(mg kg−1)	Survival rate (%)	Molecular weight (Dalton)	Weight of MPP in conjugates (%)	References
GABA	8000	100	103	0
TD (11aa)	140	100	1065	100
TAT(11aa)	27	50	1560	100
CTP(11aa)	21	50	1558	100
R11(11aa)	16.5	50	1735	100
GABA –TD	100	100	1149	92.7
GABA –TAT	19	50	1645	94.8
GABA –CTP	13	50	1644	94.8
TAT –ChAT	339	50	70000	2.2
TAT –hEGF	0.1	100	7000	22.3	Zhao et al. (2011a)
TAT –BDNF	5	100	14400	10.8	Zhou et al. (2008);
TAT –tCNTF	1	100	21664	7.2	Qu et al. (2008)
TAT ‐P53	5	100	54000	2.9	Zhao et al. (2009); Zhao et al. (2011b)
TAT ‐TH	8	100	61000	2.6	Wu et al. (2006); Fu et al. (2006);
TAT –ChAT	4	100	70000	2.2	Fu et al. (2004, 2005)

MPP, membrane‐permeable peptides; GABA, γ‐aminobutyric acid.